期刊文献+

MMP-2及TGF-β_1在人脑胶质瘤中的表达及意义

Expressions and Effects of MMP-2 and TGF-β_1 in Human Glioma
下载PDF
导出
摘要 目的探讨金属基质蛋白酶-2(MMP-2)及转化生长因子β1(TGF-β1)在人脑胶质瘤中的表达及意义。方法采用免疫组化方法对MMP-2和TGF-β1在30例胶质瘤和8例正常脑组织中的表达进行检测。结果MMP-2在正常脑组织中几乎不表达,在大多胶质瘤中均有表达,其表达水平随着胶质瘤恶性程度的增高而增高,且在正常脑组织和低(Ⅰ-Ⅱ级)、高(Ⅲ-Ⅳ)级别胶质瘤组中的表达差异显著(P<0.05);TGF-β1亦如此。同时,MMP-2与TGF-β1的表达水平呈正相关(r=0.76,P<0.01)。结论MMP-2与TGF-β1蛋白的阳性表达与肿瘤细胞病理学分级密切相关,它们参与了在人脑胶质瘤细胞的恶性转化,两者之间的协同作用可能在胶质瘤细胞的增殖中具有重要意义。 Objective To investigate the expressions and effects of matrix metalloproteinase-2 (MMP-2) and transform growth factor-β1 (TGF-β1) in human brain gliomas. Methods The expressions levels of MMP-2 and TGF-β1 in 30 cases of human gliomas and 8 specimens of normal brain tissue were detected by immunohistochemical technique. Results The positive expressions levels of MMP-2 (27.81%±8.54%) and TGF-β1 (18.22%±7.84%) in the gliomas of grades Ⅰ-Ⅱwas significantly higher than those (MMP-2: 5.78%±3.21%, TGF-β1: 8.36%±5.26%) in the normal brain tissue (P<0.05), and significantly lower than those (MMP-2: 42.71%±13.25%, TGF-β1: 39.42%±14.83%) in the gliomas of grades Ⅲ-Ⅳ (P<0.05). The expression of MMP-2 was positively correlated with that of TGF-β1 (P<0.01). Conclusion MMP-2 and TGF-β1 play the important roles in the malignization of human brain glioma.
出处 《中国临床神经外科杂志》 2004年第6期414-416,共3页 Chinese Journal of Clinical Neurosurgery
关键词 胶质瘤 金属基质蛋白酶-2 转化生长因子-Β1 Glioma Matrix metalloproteinase-2 Transform growth factor-β_1
  • 相关文献

参考文献2

二级参考文献11

  • 1Yamada N, Kato M, Yamashita H,et al . Enhanced expression of transforming growth factor-beta and its type-Ⅰ and type- Ⅱ receptors in human glioblastoma [J]. Int J Cancer,1995,62(4): 386~392.
  • 2Samuels V, Barrett JM, Bockman S, et al . Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas [J]. Am J Pathol, 1989, 134(4):895~902.
  • 3Dunn IF, Heese O, Black PM. Growth factors in glioma angiogenesis FGFs, PDGF, EGF, and TGFs [J]. J Neurooncol,2000, 50(1-2): 121~137.
  • 4Naganuma H, Sasaki A, Satoh E, et al . Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs [J]. J Neurooncol, 1998, 39: 227~236.
  • 5Ke LD, Shi YX, Im SA, et al . The relevence of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenisis and tumorigenicity in human glioma cell lines [J]. Clin Cancer Res,2000, 6(6): 2562~2572.
  • 6Fine HA, Figg WD, Jaeckle K, et al . Phase Ⅱ trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas [J]. J Clin Oncol, 2000, 18(4): 708~715.
  • 7Stan AC, Nemati MN, Pietsch T, et al . In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor [J]. J Neurosurg, 1995, 82(6): 1044~1052.
  • 8Frenz DA, Liu W, Williams JD, et al . Induction of chondrogensis: requirement for synergistic TGF-β on of basic fibroblast growth factor and transforming growth factor-beta [J]. Development, 1994, 120(2): 415~424.
  • 9Dhandapani KM, Wsde MF, Mahesh VB, et al . Basic fibroblast growth factor induces TGF-beta release in an isoform and glioma-specific manner [J]. Neuroreport, 2002, 13(2): 239~241.
  • 10章翔,步星耀,易声禹,费舟,梁景文,刘先珍.人脑胶质瘤尿激酶型纤溶酶原激活因子基因表达及意义[J].中华神经外科杂志,2000,16(4):226-228. 被引量:3

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部